Home Other Building Blocks 1372540-25-4
1372540-25-4,MFCD22417098
Catalog No.:AA009C9B

1372540-25-4 | GSK2636771

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$106.00   $74.00
- +
5mg
99% (HPLC)
in stock  
$224.00   $157.00
- +
10mg
99% (HPLC)
in stock  
$335.00   $234.00
- +
25mg
99% (HPLC)
in stock  
$637.00   $446.00
- +
50mg
≥98%
in stock  
$874.00   $612.00
- +
500mg
99% (HPLC)
in stock  
$5,515.00   $3,861.00
- +
1000mg
99% (HPLC)
in stock  
$8,787.00   $6,151.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA009C9B
Chemical Name:
GSK2636771
CAS Number:
1372540-25-4
Molecular Formula:
C22H22F3N3O3
Molecular Weight:
433.4236
MDL Number:
MFCD22417098
SMILES:
OC(=O)c1cc(cc2c1nc(n2Cc1cccc(c1C)C(F)(F)F)C)N1CCOCC1
Properties
Computed Properties
 
Complexity:
643  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
4  
XLogP3:
4  

Literature

Title: PI3K pathway dependencies in endometrioid endometrial cancer cell lines.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20130701

Title: Weigelt B, et al. PI3K pathway dependencies in endometrioid endometrial cancer cell lines. Clin Cancer Res. 2013, 19(13), 3533-3544.

Title: Hosford SR, et al. Combined inhibition of both p110α and p110β isoforms of phosphatidylinositol 3-kinase is required for sustained therapeutic effect in PTEN-deficient, ER+ breast cancer. Clin Cancer Res. 2016 Nov 30

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1372540-25-4
Tags:1372540-25-4 Molecular Formula|1372540-25-4 MDL|1372540-25-4 SMILES|1372540-25-4 GSK2636771